|Day's Range||2,416.15 - 2,497.25|
|52 Week Range||2,380.35 - 3,689.85|
|PE Ratio (TTM)||34.40|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
India's big drugmakers will need at least five more years to improve their manufacturing standards and data reliability to a level demanded by international regulators, said a senior industry official. The lengthy timeline is a concern not only in India but around the world, as India's pharmaceutical firms supply a third of the drugs sold in the United States and a large percentage in other countries.
Dr. Reddy's Laboratories Ltd. (RDY) reported fourth-quarter fiscal 2017 earnings per American Depositary Share (ADS) of 29 cents, down from 7 cents in the year-ago quarter.
On a per-share basis, the Hyderabad, India-based company said it had net income of 29 cents. The pharmaceutical posted revenue of $548 million in the period. For the year, the company reported profit of ...